What is Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)?

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) is a stock in the Healthcare sector, Medical - Distribution industry. View full analysis on Stocks360.

What is the current price of SHPMF?

The current price of SHPMF is $1.46. Prices are updated in real time on Stocks360.

What is SHPMF's price-to-earnings (PE) ratio?

SHPMF's trailing twelve-month PE ratio is 12.76, based on current price and earnings per share data available on Stocks360.

What is SHPMF's market capitalization?

SHPMF's market capitalization is $8,460,585,472.00, placing it in the mid-cap tier.

Does SHPMF pay a dividend?

Yes. SHPMF has a trailing twelve-month dividend yield of 0.03%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Stock analysis · OTC · Healthcare · Medical - Distribution

$1.46

Market Cap

$8.46B

PE (TTM)

12.76

EPS (TTM)

N/A

Dividend Yield

3.46%

Beta

0.16

Day Range

$1.46 – $1.46

52-wk Range

$1.46 – $15.70

Avg Volume

N/A

Volume

0.00

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) is a publicly traded company in the Healthcare sector. Latest price: $1.46. Market cap $8.46B. Trailing PE 12.76. Dividend yield 3.46%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $1.53 2026-10-26 · $1.46 (-4.58%)

Earnings

Most Recent

Aug 27, 2026

EPS $0.09 vs est. $0.10

Missed by $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. functions as an investment holding company deeply involved in various facets of China's pharmaceutical and healthcare sectors. Its primary activities include the research, development, production, distribution, and retail of a diverse array of medical and health-related products. The company organizes its operations across four segments: Production, Distribution, Retail, and Others. Its extensive product portfolio encompasses chemical and biochemical medications, traditional Chinese medicines, health products, and medical devices. These target a broad spectrum of therapeutic areas, such as oncology, cerebrocardiovascular conditions, central nervous system disorders, general infections, immunology, digestive and metabolic diseases, and respiratory ailments, offering approximately 700 different drug formulations. Beyond manufacturing, Shanghai Pharmaceuticals provides comprehensive pharmaceutical supply chain solutions. This includes distribution, warehousing, logistics, and various value-added services catering to drug manufacturers and healthcare providers like hospitals, other distributors, and retail pharmacies. The company also manages…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	12.76×
P/S (TTM)	0.19×
P/B	0.78×
P/FCF (TTM)	7.14×
EV / EBITDA	6.95×
EV / Sales	0.30×
Earnings Yield	7.81%
Free Cash Flow Yield	14.00%
Dividend Yield	3.46%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$85.98B
Revenue (TTM)	$289.46B
Net Income (TTM)	$4.29B
Free Cash Flow (TTM)	$8.78B
Net Debt	$31.12B
Working Capital	$47.96B
Gross Margin	10.79%
Operating Margin	2.78%
Net Margin	1.65%
Return on Equity	6.21%
Return on Invested Capital	3.64%